Dominique Vervoort MD, MPH, MBA , Hyerang Jin MSc , Frank Edwin MBChB, DA, FWACS (CTh), FGCS , Raman Krishna Kumar MD, DM, FACC, FAHA , Mahim Malik MD, FACS , Noah Tapaua MBBS, MMed (Cardiothoracic Surgery) , Amy Verstappen MGH , Babar S. Hasan MD
{"title":"全球获得儿科和先天性心脏病综合治疗的机会","authors":"Dominique Vervoort MD, MPH, MBA , Hyerang Jin MSc , Frank Edwin MBChB, DA, FWACS (CTh), FGCS , Raman Krishna Kumar MD, DM, FACC, FAHA , Mahim Malik MD, FACS , Noah Tapaua MBBS, MMed (Cardiothoracic Surgery) , Amy Verstappen MGH , Babar S. Hasan MD","doi":"10.1016/j.cjcpc.2023.10.001","DOIUrl":null,"url":null,"abstract":"<div><p>Paediatric and congenital heart disease (PCHD) is common but remains forgotten on the global health agenda. Congenital heart disease is the most frequent major congenital anomaly, affecting approximately 1 in every 100 live births. In high-income countries, most children now live into adulthood, whereas in low- and middle-income countries, over 90% of patients do not get the care they need. Rheumatic heart disease is the most common acquired cardiovascular disease in children and adolescents. While almost completely eradicated in high-income countries, over 30-40 million people live with rheumatic heart disease in low- and middle-income countries. Challenges exist in the care for PCHD and, increasingly, adult congenital heart disease (ACHD) worldwide. In this review, we summarize the current status of PCHD and ACHD care through the health systems lens of workforce, infrastructure, financing, service delivery, information management and technology, and governance. We further highlight gaps in knowledge and opportunities moving forward to improve access to care for all those living with PCHD or ACHD worldwide.</p></div>","PeriodicalId":100249,"journal":{"name":"CJC Pediatric and Congenital Heart Disease","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772812923001525/pdfft?md5=64adde3ab5bbaa251f3eb8387d82e762&pid=1-s2.0-S2772812923001525-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Global Access to Comprehensive Care for Paediatric and Congenital Heart Disease\",\"authors\":\"Dominique Vervoort MD, MPH, MBA , Hyerang Jin MSc , Frank Edwin MBChB, DA, FWACS (CTh), FGCS , Raman Krishna Kumar MD, DM, FACC, FAHA , Mahim Malik MD, FACS , Noah Tapaua MBBS, MMed (Cardiothoracic Surgery) , Amy Verstappen MGH , Babar S. Hasan MD\",\"doi\":\"10.1016/j.cjcpc.2023.10.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Paediatric and congenital heart disease (PCHD) is common but remains forgotten on the global health agenda. Congenital heart disease is the most frequent major congenital anomaly, affecting approximately 1 in every 100 live births. In high-income countries, most children now live into adulthood, whereas in low- and middle-income countries, over 90% of patients do not get the care they need. Rheumatic heart disease is the most common acquired cardiovascular disease in children and adolescents. While almost completely eradicated in high-income countries, over 30-40 million people live with rheumatic heart disease in low- and middle-income countries. Challenges exist in the care for PCHD and, increasingly, adult congenital heart disease (ACHD) worldwide. In this review, we summarize the current status of PCHD and ACHD care through the health systems lens of workforce, infrastructure, financing, service delivery, information management and technology, and governance. We further highlight gaps in knowledge and opportunities moving forward to improve access to care for all those living with PCHD or ACHD worldwide.</p></div>\",\"PeriodicalId\":100249,\"journal\":{\"name\":\"CJC Pediatric and Congenital Heart Disease\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2772812923001525/pdfft?md5=64adde3ab5bbaa251f3eb8387d82e762&pid=1-s2.0-S2772812923001525-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CJC Pediatric and Congenital Heart Disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772812923001525\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CJC Pediatric and Congenital Heart Disease","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772812923001525","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Global Access to Comprehensive Care for Paediatric and Congenital Heart Disease
Paediatric and congenital heart disease (PCHD) is common but remains forgotten on the global health agenda. Congenital heart disease is the most frequent major congenital anomaly, affecting approximately 1 in every 100 live births. In high-income countries, most children now live into adulthood, whereas in low- and middle-income countries, over 90% of patients do not get the care they need. Rheumatic heart disease is the most common acquired cardiovascular disease in children and adolescents. While almost completely eradicated in high-income countries, over 30-40 million people live with rheumatic heart disease in low- and middle-income countries. Challenges exist in the care for PCHD and, increasingly, adult congenital heart disease (ACHD) worldwide. In this review, we summarize the current status of PCHD and ACHD care through the health systems lens of workforce, infrastructure, financing, service delivery, information management and technology, and governance. We further highlight gaps in knowledge and opportunities moving forward to improve access to care for all those living with PCHD or ACHD worldwide.